Skip to main content
. 2019 Feb 19;11(2):240. doi: 10.3390/cancers11020240
ADP adenosine diphosphate
Asm acid sphingomyelinase
ATX autotaxin
BFGF basic fibroblast growth factor
CAF cancer-associated fibroblast
CD cluster differentiation
CDD cytidine deaminase
CXCR4 chemokine receptor type 4
ECM extracellular matrix
EGFR epidermal growth factor receptor
EML4-ALK echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase
EMT epithelial mesenchymal transition
EPCs epithelial progenitor cells
fL femtoliter
FLK-1 fetal liver kinase-1
GP glycoprotein
hENT human equilibrative transporter
HUVEC human umbilical vein endothelial cell
JNK c-Jun N-terminal kinases
LLC Lewis lung carcinoma
LPA lysophosphatidic acid
MHC major histocompatibility complex
MMPs matrix metalloproteinases
MPs microparticles
MPV mean platelet volume
NK natural killer
NKG2D natural killer group 2D
NPY neuropeptide Y
P2Y12 platelet ADP receptor
PAR-1 protease-activated receptor-1
PDGF platelet-derived growth factor
PDGFR platelet-derived growth factor receptor
PDW platelet distribution width
(PG)E2 EP3 prostaglandin E2 receptor subtype EP3
RTK receptor tyrosine kinase
SDF-1 stromal cell-derived factor-1
TBHS-1 thrombospondin-1
TCIPA tumor cell-induced platelet activation
TFs tissue factors
TGF-β transforming growth factor-β
TKI tyrosine kinase inhibitor
TX thromboxane
VEGF vascular endothelial growth factors